Canton Strategic Holdings (CNTN) Other financing activities (2022 - 2026)
Canton Strategic Holdings (CNTN) posted Other financing activities of $94711.0 for Q1 2026, down 96.21% on a QoQ basis from $2.5 million in Q4 2025.
Canton Strategic Holdings (CNTN) Other financing activities (2022 - 2026) Analysis & Trends
Canton Strategic Holdings' Other financing activities history runs 4 years deep, the most recent figure standing at $94711.0 for Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $94711.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (changed N/A YoY) and the FY2025 annual result came in at $3.7 million, down 9.24% from the prior year.
- Other financing activities was $94711.0 for Q1 2026 at Canton Strategic Holdings, down from $2.5 million in the prior quarter.
- Across five years, Other financing activities topped out at $3.6 million in Q4 2024 and bottomed at -$13.6 million in Q4 2022.
- A 4-year average of -$1.0 million and a median of $545587.5 in 2024 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 588.14% in 2025, while the deepest fall reached 31.44% in 2025.
- Canton Strategic Holdings' Other financing activities stood at -$13.6 million in 2022, then surged by 126.77% to $3.6 million in 2024, then slumped by 31.44% to $2.5 million in 2025, then sank by 96.21% to $94711.0 in 2026.
- Business Quant data shows CNTN's Other financing activities at $94711.0 in Q1 2026, $2.5 million in Q4 2025, and $952725.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Canton Strategic Holdings | 426.84 Mn | 426.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94,711.00 |
| Mar 31, 2026 | 94,711.00 |
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 952,725.00 |
| Sep 30, 2025 | 952,725.00 |
| Dec 31, 2024 | 3.65 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Sep 30, 2024 | 138,450.00 |
| Sep 30, 2024 | 138,450.00 |
| Dec 31, 2022 | -13.62 Mn |
| Dec 31, 2022 | -13.62 Mn |